COFCO Biotechnology Co., Ltd.

シンボルマーク: 000930.SZ

SHZ

6.57

CNY

今日の市場価格

-21.1266
PER（株価収益率
-2.7465
PEGレシオ
12.13B
MRK キャップ
0.09%
DIV利回り

COFCO Biotechnology Co., Ltd. (000930-SZ) 財務諸表

Q: COFCO Biotechnology Co., Ltd.000930.SZ 総資産とは何ですか？

COFCO Biotechnology Co., Ltd. (000930.SZ) 総資産は .

Q: 企業のフリーキャッシュフローとは？

フリーキャッシュフローは .

Download

年次四半期

リニア対数

チャート上ではのダイナミクスにおけるデフォルトの数値を見ることができる。COFCO Biotechnology Co., Ltd. (000930.SZ). 会社の収益は NaN M の平均を示し、これは NaN % の成長率です。全期間の平均売上総利益は NaN M であり、NaN % である。平均売上総利益率は NaN % である。昨年度の純利益成長率はNaN % で, NaN % % に等しい。に等しい.,

年次四半期

10Y 20Y 30Y 40Y

貸借対照表

COFCO Biotechnology Co., Ltd.の財政の軌跡に飛び込むと、平均的な資産の伸びが観察される。この率は、興味深いことに、であり、会社の最高と最低の両方を反映している。前期比で比較すると、この数字はに調整される。過去1年間を振り返ってみると、総資産の変動は NaN となる. 総株主資本によって示される株主価値は、報告通貨でのNaN で評価される。この面の前年比変化はNaN% である.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996
balance-sheet.row.cash-and-short-term-investments	1481.1	1016.6	1116	662.3	700.5	772.9	554.8	617.8	537.1	284.5	255.9	353.4	406.6	508.6	694	552.7	734.7	324.7	620.5	562.8	587	361.7	306.5	162.1	245.3	61.9	29.2	1.3
balance-sheet.row.short-term-investments	2.1	3.8	-24.4	-21.1	-26.5	-26.4	0	5.5	0	-5.8	0.6	0.3	1.2	3.8	10	0	35.6	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	1549.6	2608.5	2147	4052.6	1726.9	2861.6	688.4	469.1	509.4	826.6	694.3	566.1	626.9	558.3	380.1	539.1	1019	968.9	731.6	510.3	580.8	225.8	189.4	57.2	36.2	26.7	35.4	42
balance-sheet.row.inventory	2534.3	3763.2	4052.3	4991.5	2770	3867.3	619.1	563.4	737.8	1265.4	923	1188.3	773.6	982.5	625.3	843.3	709.6	594.6	951.6	619.2	332.6	170.8	69.2	78	40.6	36.7	28.2	23.8
balance-sheet.row.other-current-assets	470.3	282.6	319.1	195	1530.5	1904.7	36.3	21.2	31.8	-189.4	-208.7	-100.9	-92.3	-70.4	-29.5	-53.9	-174.6	141.4	-48.6	-22.3	35.9	111.1	119.4	228.6	302.1	119.4	47.6	22.7
balance-sheet.row.total-current-assets	6035.3	7671	7634.4	9901.4	6727.9	9406.5	1898.6	1671.5	1816	2187.1	1664.5	2007	1714.7	1979	1669.8	1881.2	2288.8	2029.6	2255.2	1670.1	1536.2	869.4	684.5	525.9	624.2	244.8	140.3	89.9
balance-sheet.row.property-plant-equipment-net	8678	8612	8650	8493.8	8394.1	8774.9	3397.5	3130.4	3315.9	4225.7	4420.6	4371	4283.5	4455.1	4607.6	5034.4	5065.8	5229.5	4696.8	4034.1	3001.4	2095.1	1680.8	779	431.6	245.8	167.3	100.8
balance-sheet.row.goodwill	366	366	366	366	366	366	366	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	602.7	610.6	629.7	852.7	823.9	898.9	445.6	333	342.6	340.9	356.6	368.1	354.3	375.7	359	176.7	161.4	139	57.3	16.9	8.8	5.9	0	0	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	968.7	976.6	995.8	1218.8	1189.9	1265	445.6	333	342.6	340.9	356.6	368.1	354.3	375.7	359	176.7	161.4	139	57.3	16.9	8.8	5.9	0	0	0	0	0	0
balance-sheet.row.long-term-investments	535.4	536.9	536.6	538.5	592.2	610.6	39.1	33.6	0	44.9	38.5	38.8	37.9	35.3	56.4	0	39.4	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	265	164.5	202.8	133.3	131.7	131.9	118.9	9.3	0	46.2	40.4	35.1	45.2	73	63.6	38.1	55.7	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	75.5	139.2	42.6	198.8	121	98.7	56.3	257.2	173.7	19.4	30.8	39.2	41.8	4.7	10.3	73.7	35.6	290.4	383.3	179	170.6	69.7	82.5	47	24.5	0	0	0
balance-sheet.row.total-non-current-assets	10522.5	10429.3	10427.7	10583.1	10429	10881	4057.3	3763.5	3832.2	4677.1	4886.9	4852.2	4762.6	4943.9	5096.9	5322.9	5357.8	5658.8	5137.3	4229.9	3180.8	2170.7	1763.3	826	456.1	245.8	167.3	100.8
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	16557.9	18100.3	18062.1	20484.5	17156.9	20287.6	5955.9	5435	5648.2	6864.2	6551.4	6859.1	6477.4	6922.9	6766.7	7204.1	7646.6	7688.5	7392.5	5900	4717.1	3040.1	2447.8	1351.9	1080.3	490.6	307.6	190.6
balance-sheet.row.account-payables	681.9	919.6	920.2	845.8	854.8	984.9	315.1	309	197.3	582.2	332.6	287.8	278.3	476	564	1268	1652.7	1326.8	1511.4	1316.5	912.6	511.8	376.8	276.9	132.9	100.8	63	36.7
balance-sheet.row.short-term-debt	3398.9	2929.1	2871.7	6640.2	2731.4	5158.9	2261.2	2126.9	2461.3	2118	1908.5	2203.6	2343.1	2965.7	2986	3035.9	2781.9	2432.8	2343.8	1802.3	1413.2	783.9	389.2	198.7	139.8	58.8	52	39.7
balance-sheet.row.tax-payables	47.6	91.4	64.5	119.9	78.5	119.9	46.1	42.1	24.3	6.3	18.4	-22.6	-1.9	-13	64.1	-9.9	-50.5	-6.5	5.7	-26.3	-38.3	-11.8	-8.2	34.1	36.2	27.5	12.7	8.3
balance-sheet.row.long-term-debt-total	165.6	296.9	523.7	189.7	274.7	645	535.3	377.8	564.1	688.3	779.1	853.1	373	413.6	562.3	603	983	1110	591.3	884.9	630.2	190.5	115.2	170.2	178.2	112.3	65.8	19.9
Deferred Revenue Non Current	56.5	59	50.9	64.5	67.5	62.6	18	18.9	20.6	44.2	48.2	0	0	0	0	0	-912.9	0	0	0	0	0	0	0	-178.2	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	794.7	1034.1	32.4	55.9	1633.6	3541.2	33.1	37	19.9	45.2	58.2	54.3	58.8	63.5	37.3	44.8	66.4	544.3	95.2	55.9	28.4	15.1	3.7	3.3	1.8	0.8	0.9	2.1
balance-sheet.row.total-non-current-liabilities	492.5	427.3	712.9	359.3	412.7	836.9	741.2	944.7	1108	754.6	831	942.7	617.2	438.9	592.2	616.9	1054.4	1177.6	591.4	889.5	637.2	191.2	116.3	173.6	183.9	112.3	65.8	19.9
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	196.6	105.6	117.3	121.7	17.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	5634.3	5588.8	6303.4	9682.7	6954	10641.7	3994.5	3729.2	4074.5	3760.4	3457.9	3790	3538.7	4321.2	4425	5169.6	5734.5	5667.4	4957.5	4111.9	3105.2	1534.1	1067.2	759.8	508.4	340.3	208.6	122.8
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	1864.7	1865.3	1865.7	1865.8	1847.6	1847.6	964.4	964.4	964.4	964.4	964.4	964.4	964.4	964.4	964.4	964.4	964.4	964.4	964	391.9	318.6	318.6	177	147	147	87	44.8	43
balance-sheet.row.retained-earnings	1411.7	3152.3	2601.3	1645.1	1060.4	514.4	-278.2	-500.4	-627.5	809.8	802.4	788.9	676.3	390.2	185.5	-50.2	-108.5	-50	339.6	273.4	273.4	192.4	127.2	56.2	49	15.6	46.1	21.2
balance-sheet.row.accumulated-other-comprehensive-income-loss	1226.6	1131.5	989.9	888.8	996.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	5948.5	5950.8	5940.4	5994	5923	6864.1	1117.6	1096.9	1098.7	1114.6	1105.4	1086.3	1074.9	1027.8	973.4	931.5	960.1	1002.6	993.8	1080	997.9	979.2	1065.8	388.9	376	47.7	8.1	3.7
balance-sheet.row.total-stockholders-equity	10451.6	12099.9	11397.4	10393.7	9827.4	9226.1	1803.8	1560.9	1435.6	2888.9	2872.2	2839.7	2715.7	2382.4	2123.3	1845.8	1816	1917	2297.5	1745.3	1589.9	1490.1	1370.1	592.1	571.9	150.3	99	67.9
balance-sheet.row.total-liabilities-and-stockholders-equity	16557.9	18100.3	18062.1	20484.5	17156.9	20287.6	5955.9	5435	5648.2	6864.2	6551.4	6859.1	6477.4	6922.9	6766.7	7204.1	7646.6	7688.5	7392.5	5900	4717.1	3040.1	2447.8	1351.9	1080.3	490.6	307.6	190.6
balance-sheet.row.minority-interest	402	411.6	361.3	408.1	375.5	419.8	157.6	144.9	138.2	214.9	221.3	229.4	223.1	219.3	218.4	188.7	96.1	104.1	137.6	42.8	21.9	15.9	10.5	0	0	0	0	0
balance-sheet.row.total-equity	10853.6	12511.5	11758.7	10801.8	10202.9	9645.8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	535.4	536.9	512.1	517.3	565.7	584.2	39.1	39.1	39.1	39.1	39.1	39.1	39.1	39.1	66.4	73.7	74.9	290.4	383.3	179	170.6	69.7	82.3	47	24.5	0	0	0
balance-sheet.row.total-debt	3761.1	3226	3395.4	6829.9	3006.1	5804	2796.5	2504.7	3025.3	2806.3	2687.6	3056.8	2716.1	3379.3	3548.3	3638.9	3764.9	3542.8	2935.1	2687.2	2043.4	974.4	504.4	368.9	318	171.1	117.8	59.5
balance-sheet.row.net-debt	2280	2209.4	2279.5	6167.6	2305.6	5031	2241.7	1892.4	2488.3	2521.8	2432.3	2703.7	2310.8	2874.5	2864.3	3086.3	3065.7	3218.1	2314.6	2124.4	1456.4	612.7	197.9	206.8	72.7	109.2	88.6	58.2

キャッシュフロー計算書

COFCO Biotechnology Co., Ltd. の財務状況は、直近の期間においてフリー・キャッシュ・フローに顕著な変化が見られ、NaN の推移を示している。同社は最近、NaN を発行して株式資本を拡大し、前年度と比較してNaN の差を示した. 当社の投資活動は、報告通貨で NaN に相当する正味現金使用量をもたらしました。これは、NaN の前年からのシフトです. 同時期に、同社は NaN, NaN、および NaN を記録しており、同社の投資および返済戦略を理解する上で重要です. 財務活動によるキャッシュ・フローはNaN となり、前年同期との差はNaN となった。また、NaN を株主への配当に充当した。同時に、NaN と呼ばれるその他の財務操作も行っており、これらもこの期間のキャッシュフローに大きな影響を与えた. これらの要素を総合すると、会社の財務状況とキャッシュフロー管理に対する戦略的アプローチの包括的な絵が描かれる。

common:word.in-mln USD Growth	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999
cash-flows.row.net-income	1060.9	1133	628.2	558.9	517.4	249.7	133.2	-1495	31.6	50.5	201.5	361.3	301.2	279.9	61.7	17.3	-384.8	139.1	107.1	104.7	114.1	110	86	40.6	15.6
cash-flows.row.depreciation-and-amortization	458.2	446.3	436.4	425.3	609.5	181.1	168.1	275.7	271.5	256.5	241.9	260.1	250.2	267.3	222.6	266.4	299.2	207.2	126.6	73	61.2	41.7	31.1	15.2	4.6
cash-flows.row.deferred-income-tax	36.1	-62.2	-3.3	-0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	-5	62.2	3.3	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-1261.9	2701.8	-4471.1	1670.7	-2886.4	88	340.8	190.7	-233.6	254.1	-384.4	-185.6	-477.1	-324.4	-233	675.7	-270.7	-95.3	23	-79.6	-10.4	-80.2	-16	-251.5	-22
cash-flows.row.account-receivables	-1051.9	2418.2	-2276.3	960.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	83.1	760.3	-2462.3	983.4	-1741.4	-117.8	257	418.1	-289.3	264.8	-413.8	179.8	-357.2	218.1	-133.8	-115	357	-332.4	-286.5	-161.9	-101.3	-22.7	-37.3	-3.9	0
cash-flows.row.account-payables	-329.1	-414.5	270.7	-273	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	36.1	-62.2	-3.3	-0.5	-1145	205.8	83.7	-227.3	55.6	-10.7	29.5	-365.3	-119.9	-542.5	-99.2	790.7	-627.7	237.1	309.5	82.3	90.9	-57.5	21.4	-247.6	0
cash-flows.row.other-non-cash-items	420.1	560.4	495.7	994.9	836.3	228.9	142.5	914.3	137.3	176.6	209.7	258	239	366.7	387.4	126	428	134.2	81.5	46.2	25.2	20.2	25.7	51.5	21.3
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-565.8	-1109.8	-987.5	-900.8	-868.4	-639.2	-160.5	-83.9	-129.5	-240.6	-160.7	-149.9	-178.4	-162.4	-243.9	-337.2	-444.8	-726.1	-703.4	-790.9	-503.3	-678.1	-160.4	-171.6	-7.2
cash-flows.row.acquisitions-net	305.7	160.5	107.8	151.7	0	7449.1	0	0	0	0	-19.7	0	0	0.5	0	337.2	0	0	0	0	0	0	0	0	0
cash-flows.row.purchases-of-investments	-32.6	270.4	-21.1	-32	0	-6740.9	0	0	0	0	170.9	0	0	-30.7	0	-45	-2.3	-354.3	-35.6	-238	-3.8	-58.5	-22.5	-17.5	0
cash-flows.row.sales-maturities-of-investments	14.8	1.6	6.3	106.7	47.2	2.2	5.8	5.8	5.7	3.7	3.7	3.7	32.2	6.7	5.7	191.9	2.3	8	0	0	0	0	0	0	0
cash-flows.row.other-investing-activites	-22.7	9.4	-4.5	44	-33.5	-639.2	13.8	0.6	1.2	7.9	-160.7	8.8	1.3	33.5	32.3	-337.2	107	10.2	-92.2	111.9	0.9	0.2	0	0	0
cash-flows.row.net-cash-used-for-investing-activites	-300.6	-667.9	-899	-630.4	-854.7	-568	-140.9	-77.5	-122.6	-229.1	-166.5	-137.5	-145	-152.5	-205.8	-190.3	-337.8	-1062.3	-831.2	-917	-506.2	-736.5	-182.9	-189	-7.2
cash-flows.row.debt-repayment	-6493.2	-11592.7	-5566.1	-8894.5	-7613.7	-2708.1	-3325.4	-3293.6	-3140.6	-2970.4	-3654.9	-3599.2	-4020.9	-3431	-3059.1	-3342.8	-2557.6	-1954.6	-2032.2	-1003.6	-797.2	-268.2	-170.9	-192.9	-38.7
cash-flows.row.common-stock-issued	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-554.7	-277.3	-164.4	-196	-191.5	-114.7	-131.3	-180.7	-166.1	-181.8	-212.7	-200.4	-197.6	-242.6	-302	-233.8	-206.1	-137.7	-118.6	-73.7	-41.3	-25.9	-90.6	-14.1	-7.8
cash-flows.row.other-financing-activites	6453.7	8168.4	9485.1	6000.6	9127.9	2588	2895.5	3895.4	3253.9	2550.8	3715.9	3150.3	3878.2	3367.9	2989.2	3064.9	2741.1	2829.9	2619.7	2068.7	1208.9	1083.1	234.4	723.7	79.1
cash-flows.row.net-cash-used-provided-by-financing-activities	-594.3	-3701.7	3754.6	-3089.9	1322.7	-234.8	-561.2	421	-52.9	-601.3	-151.7	-649.3	-340.3	-305.7	-371.8	-511.7	-22.6	737.6	468.9	991.3	370.3	789	-27.1	516.7	32.6
cash-flows.row.effect-of-forex-changes-on-cash	40.4	-4.3	-0.5	1.4	5.7	0.5	2.3	-4.8	-2.1	-5.1	-2.8	-6.6	-7.2	0.1	-7.6	-8.8	-7.2	-2.8	-0.1	6.5	0.9	0.2	0	0	0
cash-flows.row.net-change-in-cash	-146.1	467.7	-55.8	-69.2	-449.6	-54.7	85	224.6	29.2	-97.8	-52.2	-99.5	-179.1	131.3	-146.5	374.5	-295.8	57.6	-24.1	225.3	55.2	144.4	-83.1	183.4	44.9
cash-flows.row.cash-at-end-of-period	963	1109.1	641.4	697.2	766.4	539.4	594.1	509.1	284.5	255.3	353.1	405.4	504.8	684	552.7	699.2	324.7	620.5	562.8	587	361.7	306.5	162.1	245.3	61.9
cash-flows.row.cash-at-beginning-of-period	1109.1	641.4	697.2	766.4	1216	594.1	509.1	284.5	255.3	353.1	405.4	504.8	684	552.7	699.2	324.7	620.5	562.8	587	361.7	306.5	162.1	245.3	61.9	16.9
cash-flows.row.operating-cash-flow	708.4	4841.6	-2910.9	3649.7	-923.3	747.7	784.7	-114.2	206.8	737.7	268.7	693.9	313.3	589.4	438.7	1085.3	71.7	385.2	338.3	144.4	190.1	91.7	126.8	-144.2	19.5
cash-flows.row.capital-expenditure	-565.8	-1109.8	-987.5	-900.8	-868.4	-639.2	-160.5	-83.9	-129.5	-240.6	-160.7	-149.9	-178.4	-162.4	-243.9	-337.2	-444.8	-726.1	-703.4	-790.9	-503.3	-678.1	-160.4	-171.6	-7.2
cash-flows.row.free-cash-flow	142.7	3731.8	-3898.4	2748.9	-1791.7	108.4	624.2	-198.1	77.2	497.1	108	544	134.9	427	194.8	748.1	-373	-341	-365.1	-646.5	-313.1	-586.4	-33.6	-315.8	12.3

損益計算書の行

COFCO Biotechnology Co., Ltd. の売上は前期比 NaN% の変化。000930.SZ の売上総利益は NaN と報告されている。同社の営業費用は NaN で、前期比NaN% の変化を示している. 減価償却費は NaN であり、前期からの増減率は NaN% である。営業費用は NaN と報告されており、前年比NaN% の変化を示している。販売・マーケティング費用は NaN で、前年度比 NaN% の変化である。直近の数字に基づくEBITDAは NaN で、前年比NaN% の伸びを示す。営業利益は NaN で、前年度比NaN% の変化を示している。当期純利益の増減率は NaN%。前年度の当期純利益は NaN であった。

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996
income-statement-row.row.total-revenue	20289.8	19918.1	23468.6	19909.4	19472	17703.9	6275.9	5603.4	6457.3	7153.2	7339.9	7730.4	7401.3	5967.2	5011	4801.9	4178.1	4398.2	3261.3	2198.2	1547.4	1199.4	853.2	705.2	482.9	345.6	229	102.2
income-statement-row.row.cost-of-revenue	19341.4	17666.6	20842.8	17827.7	16735.5	14803.5	5596.5	4830.8	6482.2	6463.1	6652.7	6955.5	6695.1	5758.5	4752.4	4864.9	4471	4424.6	2922	1807.2	1260.9	954.2	660.1	503.9	381.8	268.8	169.5	69.5
income-statement-row.row.gross-profit	948.4	2251.5	2625.7	2081.7	2736.5	2900.5	679.4	772.5	-25	690.1	687.2	774.9	706.2	208.7	258.6	-63.1	-292.9	-26.4	339.4	391.1	286.5	245.2	193.1	201.3	101.1	76.8	59.5	32.7
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-534.2	75	259	400.1	-258.2	3.9	104.2	215.9	76.8	119.7	202	368	652.8	891.3	871.5	871.3	819.4	324.4	214.3	13.3	2	36	19.1	3.3	0.8	1.1	0	0.1
income-statement-row.row.operating-expenses	1403.8	553.1	752.6	860	1130	1516.3	297	607.3	588	604.1	636.2	668.1	597.7	517.7	437.6	429.5	361.5	438.9	208.9	158	96.9	89.7	75.9	77.3	42.3	25.8	18.2	9.6
income-statement-row.row.cost-and-expenses	20745.3	18219.7	21595.5	18687.7	17865.5	16319.7	5893.6	5438.1	7070.2	7067.2	7288.9	7623.6	7292.8	6276.2	5190	5294.4	4832.5	4863.5	3130.8	1965.2	1357.7	1043.9	735.9	581.2	424.1	294.6	187.7	79.1
income-statement-row.row.interest-income	16.2	16.2	15.4	10.6	9.9	5	2.1	4.1	4.6	3.2	5.1	4.2	7.3	5.4	5.5	8	36.2	37.6	12.8	5.3	5.9	2.5	7.1	2.3	0	0	0	0
income-statement-row.row.interest-expense	112.8	87.1	157.8	94.3	162.1	163.1	106.4	156	177.6	148.2	154.7	193.4	190.6	162.7	230.9	286.6	282.5	228.3	116.8	98.4	63.5	28.9	23	23.5	11.7	9.2	6.8	4.1
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-84.2	9.7	-543.5	-393.5	-990.1	-766.4	-123.3	-29.4	-861.1	-26.3	3.2	158.3	389.8	640.4	502.9	561.1	693.8	125.7	80.4	-83.8	-48.2	5.1	1.2	-24.2	-11.2	-8.1	-6.9	-4.1
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-534.2	75	259	400.1	-258.2	3.9	104.2	215.9	76.8	119.7	202	368	652.8	891.3	871.5	871.3	819.4	324.4	214.3	13.3	2	36	19.1	3.3	0.8	1.1	0	0.1
income-statement-row.row.total-operating-expenses	-84.2	9.7	-543.5	-393.5	-990.1	-766.4	-123.3	-29.4	-861.1	-26.3	3.2	158.3	389.8	640.4	502.9	561.1	693.8	125.7	80.4	-83.8	-48.2	5.1	1.2	-24.2	-11.2	-8.1	-6.9	-4.1
income-statement-row.row.interest-expense	112.8	87.1	157.8	94.3	162.1	163.1	106.4	156	177.6	148.2	154.7	193.4	190.6	162.7	230.9	286.6	282.5	228.3	116.8	98.4	63.5	28.9	23	23.5	11.7	9.2	6.8	4.1
income-statement-row.row.depreciation-and-amortization	509.2	888.7	446.3	436.4	425.3	609.5	181.1	168.1	275.7	271.5	256.5	241.9	260.1	250.2	267.3	222.6	266.4	299.2	207.2	126.6	73	61.2	41.7	31.1	15.2	4.6	6.7	4.1
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-455.4	1350.2	1926.6	1195.5	1656.4	614.2	154.9	-57.8	-1547.6	-57.1	-144	-96.8	-144.2	-557.7	-539.8	-802.8	-780	-687.9	26.9	159.2	146.6	133.5	102.7	99.3	47.3	41.8	34.6	19
income-statement-row.row.income-before-tax	-539.7	1359.9	1383.1	801.9	666.3	617.8	259.1	135.9	-1474.1	59.7	54.1	265	498.2	331.3	324	68.6	39.4	-351.5	226	160.9	145	165.1	120.1	101.2	47.8	42.9	34.5	19
income-statement-row.row.income-tax-expense	73.8	298.9	250.1	173.8	107.5	100.4	9.4	2.6	20.9	28.1	3.7	63.6	136.9	59.9	44.1	34.7	22.2	30.9	70.2	53.8	40.3	51	10.1	15.2	7.2	6.4	5.2	2.9
income-statement-row.row.net-income	-601.6	1058.5	1129.6	593.1	592.8	483	237.3	127.1	-1418	35.2	50.7	183	355.1	263.9	251.9	26.4	25.8	-384.8	139.1	101.1	98.8	110.2	110	86	40.6	36.5	29.3	16.2